Search results
The Biomarin Pharmaceutical Inc (BMRN) Company: A Short SWOT Analysis
GuruFocus.com via Yahoo Finance· 7 months agoBiomarin Pharmaceutical Inc (NASDAQ:BMRN) has a strong focus on rare-disease therapies, with several...
Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)
GuruFocus.com via Yahoo Finance· 1 month agoRobust portfolio of rare-disease therapies with a focus on genetic discovery. Strategic positioning...
BioMarin (BMRN) Q1 Earnings Top, Voxzogo Drives Sales
Zacks via Yahoo Finance· 1 year agoBioMarin (BMRN) reports encouraging first-quarter results, wherein both earnings and sales beat...
BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Stock On An Uptrend: Could Fundamentals Be Driving The...
Simply Wall St. via Yahoo Finance· 1 year agoMost readers would already be aware that BioMarin Pharmaceutical's (NASDAQ:BMRN) stock increased...
BioMarin's (BMRN) Hemophilia Gene Therapy Gets Nod in EU
Zacks via Yahoo Finance· 2 years agoBioMarin's (BMRN) Roctavian is the first gene therapy to get approval for hemophilia A in the...
BioMarin (BMRN) Hemophilia Gene Therapy BLA Gets FDA Acceptance
Zacks via Yahoo Finance· 2 years agoIf approved, BioMarin's (BMRN) valoctocogene roxaparvovec will become the first gene therapy for...
BioMarin (BMRN) Q3 Earnings Beat, Sales Miss, Ups Voxzogo View
Zacks via Yahoo Finance· 2 years agoBioMarin Pharmaceutical BMRN reported adjusted earnings of 45 cents per share in third-quarter 2022,...
Analysts Estimate BioMarin Pharmaceutical (BMRN) to Report a Decline in Earnings: What to Look Out...
Zacks via Yahoo Finance· 2 years agoBioMarin (BMRN) doesn't possess the right combination of the two key ingredients for a likely...
Wall Street Analysts See a 31% Upside in BioMarin (BMRN): Can the Stock Really Move This High?
Zacks via Yahoo Finance· 2 years agoThe mean of analysts' price targets for BioMarin (BMRN) points to a 30.9% upside in the stock. While...
Is BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Recent Stock Performance Influenced By Its...
Simply Wall St. via Yahoo Finance· 4 months agoBioMarin Pharmaceutical (NASDAQ:BMRN) has had a great run on the share market with its stock up by a...